Nurse Practitioner in Gold Canyon, AZ Accepting Medicare
7 Nurse Practitioner nurses found. Showing 1 - 7
 Mrs. Donna M Sharman, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 6724 S Kings Ranch Rd Ste 102, Gold Canyon, AZ 85118 Phone: 480-626-4999 |
Ms. Diane J Yastrub, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 9937 E Hidden Treasure Ct, Gold Canyon, AZ 85118 Phone: 516-313-5563 |
Ms. Candace Darling, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 18061 E Via Jardin, Gold Canyon, AZ 85118 Phone: 520-227-1910 |
Lucille Marie Lancaster, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 2421 S Rainbows End, Gold Canyon, AZ 85118 Phone: 480-982-4431 Fax: 480-671-0140 |
Dana Smith, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 6410 S Kings Ranch Rd Ste 1, Gold Canyon, AZ 85118 Phone: 480-761-2500 Fax: 480-288-2879 |
Amy Simmons, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 6788 S Kings Ranch Rd Ste 1, Gold Canyon, AZ 85118 Phone: 480-626-4999 Fax: 480-304-3239 |
Angela Michelle Smith, A.N.P. Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 6499 S Kings Ranch Rd, Ste 9, Gold Canyon, AZ 85218 Phone: 480-982-6000 Fax: 480-982-0265 |
News Archive
Quanterix granted $733,437 under QTDP program for Single Molecule Array platform
Quanterix Corporation, a single molecule technology company focused on developing a next generation diagnostics platform, announced today that it was awarded a total of $733,437 in grants under the Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP program recognized Quanterix's Single Molecule Array (SiMoA™) platform as a promising advance that will improve diagnosis and treatment of disease while reducing healthcare costs.
Glucosidase inhibitors hold promise as novel therapeutic agents against SARS-CoV-2
In a new study posted to the bioRxiv* preprint server, researchers from the United States report that two iminosugar glucosidase inhibitors have the ability to suppress the replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in tissue culture – at concentrations of at least 100 times lower than required for cytotoxic effects.
Online CBT can help treat gastrointestinal disorders in children
Cognitive behavioral therapy online can be useful in treating gastrointestinal disorders in children when no physical cause can be found. This is the viewpoint of researchers at Karolinska Institutet in Sweden that is described in a new study published in the journal Clinical Gastroenterology and Hepatology.
Neonatal outcomes of preterm infants born during COVID lockdowns in Melbourne, Australia
A team of researchers from Australian institutes examined the consequences of community-wide lockdowns on neonatal outcomes of preterm infants, with a secondary focus on the underlying rates of systemic inflammation in infants and mothers around the time of birth.
› Verified 2 days ago